Bloom Energy’s Historic Quarter Masks the Oracle Warrant Hanging Over Shareholders

Bloom Energy crushes Q1 expectations with revenue doubling to $751M and EPS tripling, but an Oracle warrant poses dilution risk for shareholders.

Bloom Energy just delivered the kind of quarterly report that most companies only dream about — a tripling of earnings expectations, a doubling of revenue, and a massive data center deal that redefines the scale of its ambitions. Yet for all the euphoria, a quiet filing with the SEC on April 27 serves as a reminder that not all the news is equally favorable for existing shareholders.

The fuel cell maker posted first-quarter revenue of $751 million, more than double the year-ago period and the first time in its history as a publicly traded company that it has crossed that threshold. Non-GAAP earnings per share came in at $0.44, crushing the consensus estimate of $0.13 by a factor of three. The operating result on a non-GAAP basis hit $129.7 million, a tenfold increase from the prior year, while adjusted EBITDA climbed to $143 million — roughly six times higher.

The product business was the star of the show, with revenue surging more than 200% to $653 million. Service and installation revenue played a supporting role. For the first time in a first quarter, Bloom also generated positive operating cash flow of $73.6 million, helped by customer payments for capacity reservations.

A Raised Bar for the Full Year

Management used the strong start to lift its 2026 outlook substantially. Revenue guidance now stands at $3.4 billion to $3.8 billion, up from a prior range of $3.1 billion to $3.3 billion and well above the analyst consensus of $3.25 billion. The non-GAAP gross margin is expected to reach roughly 34%, with operating income projected between $600 million and $750 million. Non-GAAP earnings per share are forecast at $1.85 to $2.25.

The new targets reflect confidence that the momentum is sustainable. More than half of Bloom’s current data center order backlog comes from customers other than Oracle, including hyperscalers, neo-cloud providers and colocation operators. That diversification reduces the risk of over-reliance on a single partner.

Project Jupiter: A Landmark Deal

Alongside the earnings release, Bloom announced a strategic contract with Oracle and BorderPlex Digital Assets to power their AI data center campus in New Mexico — known as Project Jupiter — entirely with Bloom fuel cells. The installed capacity could reach up to 2.45 gigawatts, replacing previously planned gas turbines and diesel generators with a single microgrid. Compared to turbines, the system is expected to cut NO? emissions by roughly 92% and reduce water consumption to nearly zero.

The project ranks among the largest data center microgrids in the United States. Bloom’s manufacturing capacity already stands at up to five gigawatts annually, suggesting it has the production muscle to handle the scale.

The Oracle Warrant: A Dilution Risk in Plain Sight

The same day Bloom filed its quarterly results, it also submitted a prospectus supplement with the SEC detailing a warrant held by Oracle. The technology giant has the right to purchase 3.53 million Bloom shares at an exercise price of $113.28 per share — the closing price on October 28, 2025. The warrant is immediately exercisable, either for cash or on a cashless basis, and runs until October 9, 2026.

With Bloom’s stock trading well above the exercise price, the warrant is deeply in the money. If Oracle exercises, roughly 3.5 million new shares would be issued, diluting existing holders. Bloom itself would receive no proceeds from any subsequent sale by Oracle. The company has not indicated whether Oracle intends to exercise or when.

Market Reaction: A Wild Ride After Hours

The initial after-hours response was anything but straightforward. Shares dipped nearly 4% before reversing course and climbing to around $247.80 — a gain of almost 10% from the regular session close. The stock has risen more than 1,000% over the past 12 months, from a 52-week low of $16.05, giving it a beta of 3.18 that underscores its extreme volatility.

The average analyst price target stands at $165.96, with a wide range from $55 to $251. For the second quarter, analysts expect revenue of $703.5 million and EPS of $0.25 — a step down from Q1 but still robust. Whether Bloom can sustain the valuation baked into its current share price will likely depend on continued execution and the absence of surprises from the Oracle warrant.